DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Sparks DL, Connor DJ, Sabbagh MN, Petersen RB, Lopez J, Browne P.
Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial.
Acta Neurol Scand Suppl 2006;
185: 3-7
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.